The antitrust agency paused its lawsuit against the pharmacy benefit manager while the two discuss a proposed consent agreement.
Express Scripts considering settlement in FTC insulin price lawsuit Read More »
The chief executives of UnitedHealth, CVS, Cigna and Elevance were pilloried for care denials, vertical consolidation and sky-high executive compensation during two House hearings Thursday.
Insurance CEOs’ no good, very bad day on the Hill Read More »
The robotics giant revealed on an earnings call that it won FDA clearance for several cardiac procedures and is also ramping up its presence in ambulatory surgery centers.
Intuitive pushes into cardiac robotic surgery, ASCs Read More »
The mixed data from the Phase III COAST 2 trial follows an underwhelming data drop from COAST 1 in September that Leerink Partners said “fell well below expectations.”
Sanofi Stumbles Again in Eczema—But Plans FDA Filing for OX40 Blocker Anyway Read More »
El telescopio espacial SPHEREx de la NASA, que fue lanzado al espacio en marzo de 2025, tiene por misión cartografiar todo el cielo en cuatro escaneos diferentes, creando una extensa base de datos de estrellas, galaxias, nebulosas y muchos otros objetos astronómicos. Se estima que esta …
Todo el firmamento cartografiado en colores infrarrojos Read More »
“I don’t like established science,” ACIP chairperson Kirk Milhoan said in an interview on the Why Should I Trust You? podcast. “Science is what I observe.”
ACIP Chair Questions Polio Vaccines, Values Individual Choice Over Public Benefit Read More »
Growing opposition to vaccines in the U.S., driven by recent government policy changes, makes it difficult to see a return on investment in vaccine development, Moderna CEO Stéphane Bancel said this week.
Moderna Won’t Run Phase III Vaccine Trials as Skepticism Grows in US: Bloomberg Read More »
Corxel will use the fundraising proceeds to advance the oral GLP-1 therapy CX11 through mid-stage development in the U.S., as well as prepare for its Phase III studies.
China’s Corxel Nabs $287M Series D1 to Bankroll GLP-1 Pill Read More »
The FDA’s rare pediatric disease priority review voucher program missed reauthorization at the last minute in 2024; advocates have been fighting to get it back ever since.
Rare Disease Vouchers Caught in Political Abyss. It Didn’t Have To Be This Way Read More »
¿Y si se pudieran crear nuevos materiales con solo proyectar luz a los viejos? Aunque esto pueda parecer exclusivo de la ciencia-ficción, es un objetivo que persiguen los físicos que investigan el naciente campo de la ingeniería de Floquet, un concepto teórico seg& …
